Company / Capital Expenditures
ImageneBio, Inc. Capital Expenditures History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$414.0K
FY2024
5-year range
$414.0K / $1.8M
FY2021-FY2024
Trend
-71.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $2M to $414,000 over the past 2 years.
Based on SEC 10-K filings.
$414,000 in FY2024 with a 3-year CAGR of -18.5%.
Declined from $2M to $414,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -18.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -18.5%, indicating a declining trend.
- In FY2024, capital expenditures decreased 71.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $414.0K | -71.1% |
| FY2023 | $1.4M | -18.7% |
| FY2022 | $1.8M | +129.8% |
| FY2021 | $766.0K | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026